Sleep Disorders: Diagnosis and Treatment in Respiratory Care

Sleep disorders are a group of conditions that disrupt normal sleep patterns and impair overall health, with significant implications for cardiopulmonary function. In respiratory care, these disorders are especially important because many involve abnormalities in breathing during sleep that affect ventilation and oxygenation.

Sleep is a complex physiologic process regulated by the central nervous system and circadian rhythms, and disturbances can lead to systemic complications if left untreated.

Understanding sleep disorders is essential for recognizing their impact, guiding diagnosis, and implementing effective management strategies.

What Is a Sleep Disorder?

A sleep disorder is a condition that disrupts the normal pattern, quality, or timing of sleep, leading to impaired rest and daytime functioning. These disorders can affect how easily a person falls asleep, stays asleep, or progresses through the normal stages of sleep. Common categories include sleep-disordered breathing, such as obstructive sleep apnea, insomnia, hypersomnolence disorders like narcolepsy, circadian rhythm disorders, parasomnias, and movement disorders.

Many sleep disorders are associated with abnormalities in ventilation and oxygenation, particularly during sleep. This can result in hypoxemia, hypercapnia, and fragmented sleep.

Over time, untreated sleep disorders may contribute to serious health problems, including cardiovascular disease, cognitive impairment, and reduced quality of life. Proper diagnosis and management are essential to restore normal sleep and prevent complications.

Overview of Sleep Physiology

Sleep is an organized and cyclical process that alternates between non–rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep. These stages are controlled by interactions between the brainstem, hypothalamus, and circadian pacemakers.

Non–Rapid Eye Movement (NREM) Sleep

NREM sleep consists of progressively deeper stages. During this phase, metabolic activity, heart rate, and respiratory drive gradually decrease. Muscle tone is maintained, and breathing tends to be regular and stable. As sleep deepens, the body becomes less responsive to external stimuli, and physiologic processes shift toward restoration and energy conservation.

Rapid Eye Movement (REM) Sleep

REM sleep is characterized by increased brain activity, vivid dreaming, and near-complete skeletal muscle atonia. Respiratory patterns during REM become irregular, and ventilatory control is less stable. These physiologic changes make individuals more susceptible to hypoventilation and airway collapse, particularly those with underlying respiratory or neurologic disorders.

Regulation of Breathing During Sleep

Breathing during sleep is primarily controlled by metabolic factors such as carbon dioxide levels rather than behavioral influences. Chemoreceptors play a key role in regulating ventilation by responding to changes in arterial carbon dioxide and oxygen levels.

During sleep, especially in REM, the responsiveness of the respiratory centers is reduced. This leads to a decreased ventilatory response to hypoxemia and hypercapnia. As a result, even healthy individuals may experience mild reductions in ventilation, while those with preexisting conditions may develop significant abnormalities.

Classification of Sleep Disorders

Sleep disorders can be broadly classified into several categories based on their underlying mechanisms and clinical presentation:

• Sleep-disordered breathing
• Insomnia disorders
• Hypersomnolence disorders
• Circadian rhythm sleep-wake disorders
• Parasomnias
• Sleep-related movement disorders

Note: Among these, sleep-disordered breathing is the most relevant in respiratory care due to its direct impact on ventilation and gas exchange.

Sleep-Disordered Breathing

Sleep-disordered breathing encompasses conditions characterized by abnormal respiratory patterns during sleep. These disorders can lead to intermittent hypoxemia, hypercapnia, and fragmented sleep, contributing to both short-term symptoms and long-term complications.

Definition of Apnea and Hypopnea

Apnea is defined as the cessation of airflow for at least 10 seconds. Hypopnea refers to a reduction in airflow that is associated with oxygen desaturation or arousal from sleep. These events are quantified using the apnea–hypopnea index (AHI), which measures the number of events per hour of sleep and is used to determine the severity of the disorder.

Clinical Significance

Repeated apneic and hypopneic events disrupt normal sleep architecture and impair oxygenation. Over time, these disturbances can lead to excessive daytime sleepiness, impaired cognitive function, and increased risk of cardiovascular disease.

Obstructive Sleep Apnea (OSA)

Obstructive sleep apnea is the most common form of sleep-disordered breathing and is a major focus in respiratory therapy.

Pathophysiology

OSA occurs due to repetitive collapse of the upper airway during sleep despite continued respiratory effort. This collapse is typically caused by reduced muscle tone in the pharyngeal airway, which allows soft tissues to obstruct airflow.

When the airway becomes obstructed, airflow ceases or is significantly reduced, leading to hypoxemia and hypercapnia. The body responds with brief arousals that restore muscle tone and reopen the airway. However, these repeated arousals fragment sleep and prevent progression into deeper restorative stages.

Risk Factors

Several factors increase the likelihood of developing OSA:

• Obesity, which contributes to airway narrowing
• Male gender
• Advancing age
• Craniofacial abnormalities such as micrognathia
• Enlarged tonsils or adenoids
• Deviated nasal septum
• Alcohol or sedative use, which reduces muscle tone
• Hypothyroidism

Clinical Manifestations

Patients with OSA often present with:

• Loud, habitual snoring
• Witnessed apneic episodes during sleep
• Excessive daytime sleepiness
• Morning headaches
• Difficulty concentrating or memory impairment
• Mood changes or irritability
• Nocturnal awakenings or choking sensations

Note: In some cases, patients may also experience nocturnal enuresis or sexual dysfunction.

Physiologic Consequences

OSA has significant systemic effects due to repeated episodes of hypoxemia and sympathetic activation. These include:

• Systemic hypertension
• Pulmonary hypertension
• Cardiac arrhythmias
• Increased risk of coronary artery disease
• Increased risk of stroke

Note: Chronic exposure to intermittent hypoxia can also lead to inflammation and endothelial dysfunction, further contributing to cardiovascular disease.

Central Sleep Apnea (CSA)

Central sleep apnea is less common than OSA but is clinically important due to its distinct mechanism.

Pathophysiology

CSA is characterized by a lack of respiratory effort resulting from impaired central nervous system signaling. During apneic episodes, both airflow and respiratory effort are absent because the brain temporarily fails to stimulate the respiratory muscles.

This condition reflects a failure of the respiratory control centers, particularly in the medulla, rather than an issue with airway obstruction.

Associated Conditions

CSA is often linked to underlying medical conditions, including:

• Heart failure
• Neurologic disorders affecting the brainstem
• Spinal cord injuries
• Chronic opioid use
• Hypothyroidism

Note: A specific pattern known as Cheyne-Stokes respiration is commonly seen in patients with heart failure. It is characterized by a cyclical pattern of increasing and decreasing tidal volumes followed by periods of apnea.

Clinical Features

Symptoms of CSA may overlap with those of OSA and include:

• Fragmented sleep
• Daytime fatigue
• Insomnia
• Morning headaches

Note: However, snoring is less prominent compared to OSA.

Mixed Sleep Apnea

Mixed sleep apnea is a combination of obstructive and central components. It typically begins as a central apnea with no respiratory effort and then transitions into an obstructive event as respiratory effort resumes but airflow remains blocked.

This type of apnea highlights the complex interaction between neurologic control and airway mechanics in sleep-disordered breathing.

Indications for Sleep Evaluation

Patients with suspected sleep disorders should undergo further evaluation when certain clinical features are present. Indications for a sleep study include:

• Loud snoring associated with obesity or disrupted sleep
• Excessive daytime sleepiness
• Insomnia with suspected breathing abnormalities
• Nocturnal cardiac arrhythmias
• Morning headaches
• Chronic fatigue or somnolence
• Evidence of hypoventilation in patients with chronic lung disease
• Pulmonary hypertension or unexplained polycythemia

Note: Early identification of these signs is important for preventing complications and initiating appropriate treatment.

Diagnostic Testing: Polysomnography

Polysomnography is the gold standard for diagnosing sleep disorders, particularly sleep-disordered breathing. This comprehensive test records multiple physiologic parameters during sleep to assess both sleep architecture and respiratory function.

Components of Polysomnography

A typical sleep study includes monitoring of:

• Oxygen saturation
• Airflow through the nose and mouth
• Respiratory effort using chest and abdominal movements
• Electroencephalography to determine sleep stages
• Eye movements to identify REM sleep
• Muscle activity
• Electrocardiogram for cardiac rhythm
• Limb movements
• Body position

Note: These measurements allow clinicians to identify apneic events, classify the type of sleep disorder, and determine its severity.

Apnea–Hypopnea Index (AHI)

The severity of sleep apnea is commonly assessed using the AHI:

• Mild: 5 to 14 events per hour
• Moderate: 15 to 29 events per hour
• Severe: 30 or more events per hour

Note: This index is essential for guiding treatment decisions and monitoring response to therapy.

Screening Methods

While polysomnography is definitive, screening tools can help identify patients who require further evaluation.

Overnight Pulse Oximetry

Overnight pulse oximetry is a simple and cost-effective screening method. It measures oxygen saturation continuously during sleep and can reveal patterns suggestive of sleep apnea.

Findings that raise concern include:

• Recurrent oxygen desaturation episodes
• Drops in oxygen saturation of at least 4 percent
• Sustained oxygen levels below 90 percent

Note: Although useful, pulse oximetry cannot distinguish between different types of sleep apnea and must be followed by a formal sleep study for diagnosis.

Management of Sleep-Disordered Breathing

Effective management of sleep-disordered breathing depends on identifying the underlying cause and selecting appropriate therapy to restore normal ventilation, oxygenation, and sleep architecture.

Continuous Positive Airway Pressure (CPAP)

Continuous positive airway pressure is the first-line treatment for obstructive sleep apnea. It delivers a constant level of positive pressure throughout the respiratory cycle, which acts as a pneumatic splint to keep the upper airway open during sleep.

By preventing airway collapse, CPAP eliminates apneic events, improves oxygenation, and restores normal sleep patterns. Typical pressure settings in adults range from 7 to 12 cmH2O, although individual requirements vary based on severity and patient characteristics.

Patient adherence is critical for success. Common barriers include discomfort with the mask, nasal dryness, and claustrophobia. Proper mask fitting, humidification, and patient education can significantly improve compliance.

Bilevel Positive Airway Pressure (BiPAP)

Bilevel positive airway pressure provides two levels of pressure:

• Inspiratory positive airway pressure, which supports ventilation and increases tidal volume
• Expiratory positive airway pressure, which helps maintain airway patency

Note: BiPAP is often used when CPAP is not tolerated or when patients have coexisting hypoventilation disorders. It is particularly beneficial in patients with central sleep apnea, neuromuscular disease, or obesity hypoventilation syndrome.

Other Treatment Options for Obstructive Sleep Apnea

In addition to positive airway pressure therapy, several adjunctive strategies may be used:

• Weight loss, which reduces upper airway obstruction in obese patients
• Positional therapy to avoid sleeping in the supine position
• Oral appliances that reposition the tongue or mandible
• Surgical interventions to remove or reduce obstructing tissue
• Avoidance of alcohol and sedatives before sleep

Note: These interventions are often used in combination with primary therapy to improve outcomes.

Management of Central Sleep Apnea

The treatment of central sleep apnea focuses on addressing the underlying cause and improving ventilatory control.

Addressing Underlying Conditions

Conditions such as heart failure, neurologic disorders, and medication effects must be managed appropriately. Optimizing cardiac function, adjusting opioid therapy, or treating endocrine disorders can reduce the frequency of central apneic events.

Ventilatory Support

Noninvasive ventilation, such as BiPAP, may be used to support breathing and stabilize ventilation. In some cases, adaptive servo-ventilation may be considered to regulate breathing patterns more precisely.

Other approaches include:

• Supplemental oxygen therapy to reduce hypoxemia
• Negative-pressure ventilation in select cases
• Phrenic nerve stimulation for carefully selected patients

Evaluation of Treatment Effectiveness

The effectiveness of therapy should be monitored through both clinical improvement and objective data.

Successful treatment is indicated by:

• Elimination or significant reduction of apneic and hypopneic events
• Improved oxygen saturation during sleep
• Restoration of normal sleep architecture
• Resolution of daytime symptoms such as fatigue and sleepiness
• Reduction in snoring and abnormal breathing patterns

Note: Follow-up sleep studies or device monitoring data are often used to assess treatment adequacy and guide adjustments.

Insomnia Disorders

Insomnia is one of the most common sleep disorders and is characterized by difficulty initiating or maintaining sleep, or experiencing nonrestorative sleep despite adequate opportunity.

Causes and Risk Factors

Insomnia can be classified as acute or chronic and is often associated with:

• Psychological stress or anxiety
• Depression or other mental health conditions
• Poor sleep hygiene
• Chronic medical conditions
• Medication use

Note: Environmental factors, such as noise or irregular schedules, can also contribute.

Clinical Manifestations

Patients with insomnia may report:

• Difficulty falling asleep
• Frequent awakenings during the night
• Early morning awakening
• Daytime fatigue or irritability
• Difficulty concentrating

Note: Chronic insomnia can impair quality of life and increase the risk of comorbid conditions.

Management

Treatment typically involves nonpharmacologic approaches as the first line. Cognitive behavioral therapy for insomnia focuses on improving sleep habits and addressing negative thought patterns related to sleep. Key components include stimulus control, sleep restriction, and relaxation techniques.

Pharmacologic therapy may be used for short-term management but is generally not recommended for long-term use due to potential side effects and dependence.

Hypersomnolence Disorders

Hypersomnolence disorders are characterized by excessive daytime sleepiness despite adequate or prolonged nighttime sleep.

Narcolepsy

Narcolepsy is a neurologic disorder caused by dysregulation of sleep-wake control mechanisms.

Clinical Features

• Excessive daytime sleepiness
• Sudden sleep attacks
• Cataplexy, which is a sudden loss of muscle tone triggered by emotions
• Sleep paralysis
• Hypnagogic hallucinations

Note: These symptoms can significantly interfere with daily functioning and safety.

Management

Treatment focuses on improving alertness and managing symptoms.

• Stimulant medications are commonly used to reduce daytime sleepiness
• Scheduled naps may help maintain alertness
• Lifestyle modifications, including consistent sleep schedules, are important

Circadian Rhythm Sleep-Wake Disorders

Circadian rhythm disorders occur when the internal biologic clock is misaligned with environmental cues.

Common Types

• Shift work disorder, seen in individuals who work nontraditional hours
• Jet lag, resulting from rapid travel across time zones
• Delayed or advanced sleep phase disorders

Clinical Impact

These disorders lead to insomnia or excessive sleepiness at inappropriate times, impairing performance and overall health.

Management

Treatment strategies include:

• Light therapy to reset circadian rhythms
• Gradual adjustment of sleep schedules
• Strategic use of melatonin in some cases
• Behavioral modifications to improve sleep consistency

Parasomnias

Parasomnias are abnormal behaviors or experiences that occur during sleep or transitions between sleep and wakefulness.

Types of Parasomnias

• Sleepwalking
• Night terrors
• REM sleep behavior disorder

Clinical Considerations

While many parasomnias are benign, some can pose safety risks due to injury during episodes. REM sleep behavior disorder is particularly important because it may be associated with underlying neurologic conditions.

Management

Management focuses on ensuring patient safety and addressing contributing factors. In some cases, medications or behavioral interventions may be required.

Sleep-Related Movement Disorders

Movement disorders can significantly disrupt sleep and impair restfulness.

Restless Legs Syndrome (RLS)

RLS is characterized by an uncomfortable sensation in the legs accompanied by an urge to move them. Symptoms typically worsen at night and interfere with the ability to fall asleep.

Periodic Limb Movement Disorder

This condition involves repetitive limb movements during sleep that can cause frequent arousals and fragmented sleep.

Management

Treatment may include:

• Addressing underlying deficiencies, such as iron deficiency
• Medications to reduce symptoms
• Lifestyle changes, including reducing caffeine intake

Role of the Respiratory Therapist

Respiratory therapists play an essential role in the diagnosis and management of sleep disorders, particularly those involving disordered breathing.

Clinical Responsibilities

• Conducting and monitoring sleep studies
• Assisting with CPAP and BiPAP titration
• Educating patients on device use and adherence
• Troubleshooting equipment issues
• Monitoring patient progress and outcomes

Note: Their involvement ensures that patients receive effective therapy and maintain long-term compliance.

Clinical and Exam Considerations

Several key concepts are frequently emphasized in clinical practice and examinations:

• Obstructive apnea involves respiratory effort without airflow
• Central apnea involves absence of both effort and airflow
• Mixed apnea combines features of both types
• CPAP is the first-line treatment for obstructive sleep apnea
• Polysomnography is the gold standard diagnostic test

Note: Understanding these principles is essential for accurate diagnosis and effective management.

Systemic Consequences of Sleep Disorders

Untreated sleep disorders can have widespread effects on multiple organ systems.

Cardiovascular Effects

• Systemic hypertension
• Pulmonary hypertension
• Cardiac arrhythmias
• Increased risk of myocardial infarction and stroke

Respiratory Effects

• Chronic hypoxemia
• Hypercapnia
• Impaired ventilatory control

Neurologic and Cognitive Effects

• Impaired concentration and memory
• Increased risk of accidents
• Mood disturbances

Metabolic Effects

• Insulin resistance
• Increased risk of type 2 diabetes
• Weight gain

Note: These complications highlight the importance of early diagnosis and intervention.

Sleep Disorders Practice Questions

1. What is a sleep disorder?
A sleep disorder is a condition that disrupts normal sleep patterns and can impair overall health.

2. Why are sleep disorders important in respiratory care?
Because many involve abnormalities in breathing that affect ventilation and oxygenation during sleep.

3. What are the two main types of sleep stages?
Non–rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep.

4. What happens to respiratory drive during NREM sleep?
It decreases as sleep becomes deeper.

5. How does breathing change during REM sleep?
It becomes irregular and less stable.

6. What primarily controls breathing during sleep?
Metabolic factors such as carbon dioxide levels.

7. What is sleep-disordered breathing?
A group of conditions involving abnormal respiratory patterns during sleep.

8. What is apnea?
Cessation of airflow for at least 10 seconds.

9. What is hypopnea?
A reduction in airflow associated with oxygen desaturation or arousal.

10. What does the apnea–hypopnea index (AHI) measure?
The number of apneic and hypopneic events per hour of sleep.

11. What is the most common type of sleep apnea?
Obstructive sleep apnea (OSA)

12. What causes obstructive sleep apnea?
Collapse of the upper airway during sleep.

13. In OSA, is respiratory effort present or absent?
Respiratory effort is present.

14. What is a major risk factor for OSA?
Obesity

15. What is a common symptom of OSA?
Loud snoring

16. What causes arousals in OSA?
Hypoxemia and hypercapnia from airway obstruction.

17. What is a long-term complication of untreated OSA?
Systemic hypertension

18. What is central sleep apnea (CSA)?
A disorder where there is no respiratory effort due to lack of CNS signaling.

19. In CSA, what happens to airflow and effort?
Both airflow and effort are absent.

20. What condition is commonly associated with Cheyne-Stokes respiration?
Heart failure

21. What characterizes Cheyne-Stokes respiration?
A cyclic pattern of increasing and decreasing breathing followed by apnea.

22. What is mixed sleep apnea?
A combination of central and obstructive apnea.

23. What is a key symptom indicating the need for a sleep study?
Excessive daytime sleepiness.

24. What is the gold standard test for diagnosing sleep disorders?
Polysomnography

25. What does polysomnography measure?
Multiple parameters including airflow, oxygen saturation, EEG, and respiratory effort.

26. What physiologic change during sleep increases the risk of airway collapse?
Decreased muscle tone in the upper airway.

27. Why does REM sleep increase the risk of hypoventilation?
Because of muscle atonia and reduced ventilatory control.

28. What is a common morning symptom of sleep apnea?
Headaches

29. How does sleep apnea affect sleep architecture?
It causes fragmentation due to repeated arousals.

30. What cardiovascular condition is strongly linked to OSA?
Systemic hypertension

31. What type of sleep apnea involves a neurologic control problem?
Central sleep apnea

32. What role does the medulla play in respiration during sleep?
It regulates respiratory drive and rhythm.

33. What is a common cause of central sleep apnea?
Heart failure

34. How does obesity contribute to OSA?
By narrowing the upper airway and increasing tissue mass.

35. What is the purpose of a sleep study?
To evaluate sleep stages and identify breathing abnormalities.

36. What is one limitation of overnight pulse oximetry?
It cannot distinguish between types of sleep apnea.

37. What oxygen saturation level during sleep is concerning?
Below 90 percent.

38. What percentage drop in SpO2 is suggestive of apnea events?
A drop of 4 percent or more.

39. What is the primary treatment for obstructive sleep apnea?
Continuous positive airway pressure (CPAP).

40. How does CPAP prevent airway collapse?
By providing constant positive pressure to keep the airway open.

41. What is a typical CPAP pressure range in adults?
7 to 12 cmH2O

42. What is BiPAP used for in sleep disorders?
To provide different inspiratory and expiratory pressures.

43. What does IPAP do in BiPAP therapy?
It supports ventilation and increases tidal volume.

44. What does EPAP do in BiPAP therapy?
It maintains airway patency.

45. What lifestyle change is important for managing OSA?
Weight loss

46. Why should patients with OSA avoid alcohol before sleep?
Because it reduces muscle tone and worsens airway collapse.

47. What type of device can reposition the jaw to treat OSA?
An oral appliance.

48. What is the treatment focus for central sleep apnea?
Addressing the underlying cause.

49. What type of therapy may be used for CSA patients with hypoventilation?
Noninvasive ventilation, such as BiPAP.

50. What is one sign that sleep apnea treatment is effective?
Reduction or elimination of apneic events.

51. What is insomnia?
A disorder characterized by difficulty initiating or maintaining sleep despite adequate opportunity.

52. What type of insomnia lasts for a short duration?
Acute insomnia

53. What type of insomnia persists for months or longer?
Chronic insomnia

54. What psychological factor commonly contributes to insomnia?
Anxiety

55. What behavioral therapy is commonly used to treat insomnia?
Cognitive behavioral therapy for insomnia (CBT-I).

56. What is a key goal of CBT-I?
To improve sleep habits and change negative thoughts about sleep.

57. Why are sleep medications typically limited in use?
Due to the risk of dependence and side effects.

58. What are hypersomnolence disorders?
Conditions characterized by excessive daytime sleepiness.

59. What is the primary symptom of narcolepsy?
Excessive daytime sleepiness.

60. What is cataplexy?
A sudden loss of muscle tone triggered by strong emotions.

61. What is sleep paralysis?
A temporary inability to move or speak during sleep-wake transitions.

62. What are hypnagogic hallucinations?
Vivid dream-like experiences occurring while falling asleep.

63. What type of disorder involves misalignment of the biologic clock?
Circadian rhythm sleep-wake disorder.

64. What is shift work disorder?
A circadian disorder caused by working nontraditional hours.

65. What causes jet lag?
Rapid travel across multiple time zones.

66. What is a common treatment for circadian rhythm disorders?
Light therapy

67. What hormone is sometimes used to regulate sleep cycles?
Melatonin

68. What are parasomnias?
Abnormal behaviors or experiences during sleep.

69. What is sleepwalking?
A parasomnia involving walking or performing activities while asleep.

70. What are night terrors?
Episodes of intense fear during sleep, often with limited recall.

71. What is REM sleep behavior disorder?
A condition where patients act out dreams due to lack of muscle atonia.

72. What is restless legs syndrome (RLS)?
A disorder causing an urge to move the legs due to discomfort.

73. When are RLS symptoms typically worse?
At night.

74. What is periodic limb movement disorder?
Repetitive limb movements during sleep that disrupt rest.

75. What deficiency is commonly associated with RLS?
Iron deficiency

76. What is a key diagnostic threshold for sleep apnea based on events?
At least 30 apneic episodes during 6 hours of sleep.

77. What does fragmented sleep refer to?
Repeated interruptions in sleep due to arousals.

78. How does sleep apnea affect daytime functioning?
It causes fatigue, reduced alertness, and impaired concentration.

79. What is nocturnal enuresis in the context of sleep apnea?
Involuntary urination during sleep.

80. What structural feature can increase the risk of OSA?
A short, thick neck.

81. How can enlarged tonsils contribute to OSA?
By narrowing the upper airway.

82. What is micrognathia?
A condition where the jaw is abnormally small.

83. What endocrine disorder is associated with sleep apnea?
Hypothyroidism

84. What is paradoxical breathing in sleep disorders?
Opposite movement of the chest and abdomen during breathing.

85. What is the primary role of oxygen therapy in sleep apnea?
To improve oxygenation during sleep.

86. Why is polysomnography preferred over screening tests?
It provides comprehensive data on sleep and respiratory function.

87. What parameter in polysomnography determines sleep stages?
Electroencephalogram (EEG)

88. What does airflow monitoring detect in a sleep study?
The presence or absence of breathing.

89. What does chest and abdominal movement indicate?
Respiratory effort

90. Why is ECG included in polysomnography?
To monitor cardiac rhythm during sleep.

91. What is one sign of untreated sleep apnea during the night?
Repeated oxygen desaturation.

92. How can sleep apnea contribute to pulmonary hypertension?
Through chronic hypoxemia causing vasoconstriction.

93. What type of sleep disorder is narcolepsy classified as?
A hypersomnolence disorder.

94. What symptom of narcolepsy is triggered by laughter or emotion?
Cataplexy

95. What is the effect of chronic fatigue from sleep disorders?
Reduced quality of life and impaired daily functioning.

96. What is a key role of respiratory therapists in sleep medicine?
Managing CPAP therapy.

97. What is CPAP titration?
Adjusting pressure settings to eliminate apneic events.

98. Why is patient education important for CPAP use?
To improve adherence and treatment success.

99. What is one behavioral strategy to improve sleep quality?
Maintaining a consistent sleep schedule.

100. Why is early diagnosis of sleep disorders important?
To prevent long-term complications and improve outcomes.

Final Thoughts

Sleep disorders are a diverse group of conditions that disrupt normal sleep and can significantly impact respiratory function and overall health. Sleep-disordered breathing, particularly obstructive sleep apnea, is of major importance due to its effects on ventilation, oxygenation, and cardiovascular stability.

Accurate diagnosis through polysomnography and appropriate treatment, such as CPAP therapy, are essential for improving patient outcomes.

A thorough understanding of the underlying mechanisms and clinical presentation allows healthcare providers to recognize these disorders early and implement effective management strategies that improve both sleep quality and long-term health.